Decision analysis model for clinical stage I now seminomatous germ cell testicular cancer

被引：0
|
作者：
Nguyen, Carvell T.
Fu, Alex Z.
Gilligan, Timothy D.
Kattan, Michael W.
Wells, Brian J.
Klein, Eric A.
Stephenson, Andrew J.
机构：
来源：
JOURNAL OF UROLOGY | 2008年 / 179卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(08)60503-0
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：174 / 174
页数：1
相关论文
共 50 条
  • [1] Defining the Optimal Treatment for Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer Using Decision Analysis
    Nguyen, Carvell T.
    Fu, Alex Z.
    Gilligan, Timothy D.
    Wells, Brian J.
    Klein, Eric A.
    Kattan, Michael W.
    Stephenson, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) : 119 - 125
  • [2] Clinical outcomes in patients with stage I non-seminomatous germ cell cancer
    Lv, Zhao-Jie
    Wu, Song
    Dong, Pei
    Yao, Kai
    He, Yin-Yin
    Gui, Yao-Ting
    Zhou, Fang-Jian
    Liu, Zhuo-Wei
    Cai, Zhi-Ming
    ASIAN JOURNAL OF ANDROLOGY, 2013, 15 (04) : 558 - 563
  • [3] THE IMPACT OF PATHOLOGICAL RISK FACTORS AND THE MANAGEMENT OF STAGE I NON SEMINOMATOUS GERM CELL TESTICULAR CANCER
    Alsinnawi, Mazen
    Akapame, Sydney
    Burns, John
    Flores, John Paul
    Porter, Christopher
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1015 - E1016
  • [4] Management of clinical stage I nonseminomatous germ cell testicular cancer
    Choueiri, Toni K.
    Stephenson, Andrew J.
    Gilligan, Timothy
    Klein, Eric A.
    UROLOGIC CLINICS OF NORTH AMERICA, 2007, 34 (02) : 137 - +
  • [5] LAPAROSCOPIC RETROPERITONEAL LYMPH NODE DISSECTION FOR NON SEMINOMATOUS GERM CELL TESTICULAR TUMOR IN CLINICAL STAGE I
    Knezevic, N.
    Kulis, T.
    Maric, M.
    Bernat, M. M.
    Marijana, M.
    Kastelan, Z.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 640 - 640
  • [6] Current management of stage I testicular non-seminomatous germ cell tumours
    Pectasides, D.
    Pectasides, E.
    Constantinidou, A.
    Aravantinos, G.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 70 (02) : 114 - 123
  • [7] Surveillance versus adjuvant chemotherapy in stage I non-seminomatous testicular cancer: A decision analysis
    Stiggelbout, AM
    Kiebert, GM
    deHaes, JCJM
    Keizer, HJ
    Stoter, G
    deWit, R
    Vermorken, JB
    Leer, JWH
    Kievit, J
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (13) : 2267 - 2274
  • [8] Is a risk-adapted therapy possible in clinical stage I non-seminomatous testicular germ cell tumors?
    Heidenreich, A
    Neubauer, S
    Moul, JW
    AKTUELLE UROLOGIE, 1998, 29 (03) : 93 - 102
  • [9] ''Wait and see'' policy for patients with clinical stage I non-seminomatous testicular germ cell tumors (NSTGCT)
    Koops, HS
    Gels, ME
    Hoekstra, HJ
    Sleijfer, DT
    Marrink, J
    deBruyn, HWA
    Molenaar, WM
    Freling, NJM
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 919 - 919
  • [10] The clinical outcome and incidence of teratoma in the retroperitoneum for men with clinical stage is now seminomatous germ cell tumors
    Dash, A
    Carver, BS
    Stasi, J
    Bajorin, DF
    Bosl, GJ
    Sheinfeld, J
    JOURNAL OF UROLOGY, 2006, 175 (04): : 147 - 147
12345